We're creating a positive news network. We need your help.
A
recent study conducted by Andras Biokei-Gorzo at the Institute of
Molecular Psychiatry at the University of Bonn in Germany is suggesting
that marijuana(or the activation of the brain’s cannabinoid system)
triggers the release of antioxidants, which act as a cleansing
mechanism. This process is known to remove damaged cells and improve the
efficiency of mitochondria. Mitochondria is the energy source that
powers cells. The study was published in Philosophical Transactions Of The Royal Society, B. You can read the entire study here.
These discoveries shed new insight on
how natural marijuana cannabinoids hold the capacity to literally kill
the brain inflammation responsible for causing cognitive decline, neural
failure, and brain degeneration. By supplying these receptor sites with
cannabinoids, patients may be able to overcome brain conditions like
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and
more, not to mention premature brain aging. The human brain contains an
extensive network of special receptor sites that modulate nervous system
function only when activated by the appropriate cannabinoid compounds,
which are found in the marijuana plant.
Cannabinoids refer to any of a group of
related compounds that include cannabinol and the active constituents of
cannabis. They activate canbinoid receptors in the body. The body
itself produces compounds called endocannabinoids and they play a role
in many processes within the body that help to create a healthy
environment. Cannabinoids also play a role in immune system generation
and re-generation. The body regenerates best when it’s saturated with
Phyto-Cannabinoids. Cannabinoids can also be found in Cannabis.
Cannabinoids may very well be the best cancer fighting substance out
there!
Cannabinoid system activity is neuroprotective, and increasing it could be a promising strategy for slowing down the progression of brain aging and for alleviating the systems of neurodegenerative disorders -Andras Biokei
Gery Wenk, a professor of neuroscience,
immunology and medical genetics at Ohio State University conducted some
of the research that came out of the study from Germany. He stated that
this is a positive step, and that it is encouraging to see the potential
development of cannabinoid solutions without going overboard. Here is
what he said.
I’ve been trying to find a drug that will reduce brain inflammation and restore cognitive function in rats for over 25 years; cannabinoids are the first and only class of drugs that have ever been effective. I think that the perception about this drug is changing and in the future people will be less fearful. – Gerry Wenk, Professor of neuroscience, immunology and medical genetics at Ohio State University
Biokei-Gorzo and his collegues said that
the greatest hurdle for moving forward with their research are the
social and political challenges. This isn’t something new, our world
seems to be dominated by belief systems instead of obvious fact. It’s
discouraging to see beliefs and persuasion overrule truth. At the same
time it’s very encouraging to see truth slowly creep its way into the
norm. That’s always how it has been done throughout human history. It’s
quite evident that the powers that be do not want to legalize marijuana,
and we know that they do not have our best interest at hand. If it was
legalized, I’m sure it would be distributed and tweaked by big
pharmaceutical companies.
On the other hand there have been a
number of studies that show how marijuana can actually reduce brain
power and impair working memory. The amount of studies that show the
potential benefits of marijuana is outstanding, and the potential
harmful effects are in the few, if any at all. As far as medicinal use
goes, I think that is a no brainer. I definitely believe nature intended
marijuana to be used for its health and healing properties.
Sources:
http://cannabisinternational.org/http://edrv.endojournals.org/content/27/1/73.fullhttp://cannabisclinicians.org/wp-content/uploads/2011/12/OS-2011-Terpenes+Minor-CBs.pdf
